Microchip officer Sanghi proposes $7.16M stock sale

A separate three-month table lists three sales by Steve Sanghi, dated February 12, April 23 and April 30, 2026.

Accepted by SEC EDGAR 05/01/2026 - 03:29 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Microchip Technology Inc. officer Steve Sanghi reported a proposed sale of 76,469 shares of common stock, with an aggregate market value of $7,156,297.84. The proposed shares are from the Sanghi Trust U/A 1/13/88. The approximate sale date is May 1, 2026; for Rule 10b5-1 reliance, June 6, 2025 is listed as the plan adoption or instruction date.

Key Figures

Proposed sale: 76,469 shares Aggregate market value: $7,156,297.84 Shares outstanding: 541,135,458 shares +3 more

6 metrics

Proposed sale 76,469 shares Common stock

Aggregate market value $7,156,297.84 Proposed sale

Shares outstanding 541,135,458 shares Common stock

Shares sold 94,869 shares February 12, 2026

Shares sold 416,581 shares April 23, 2026

Shares sold 33,502 shares April 30, 2026

Key Terms

Rule 10b5-1, Option exercise, RSU Vested

3 terms

Rule 10b5-1 regulatory

"relying on Rule 10b5-1"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Option exercise financial

"Option exercise"

RSU Vested financial

"RSU Vested"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MCHP shares is Steve Sanghi proposing to sell?

The proposed sale is 76,469 shares of common stock from the Sanghi Trust U/A 1/13/88, with an approximate sale date of May 1, 2026. The stated aggregate market value is $7,156,297.84.

What recent sales did Steve Sanghi report for MCHP?

The past-three-month table lists 94,869 shares sold February 12, 2026 for gross proceeds of $7,823,191.83; 416,581 shares sold April 23, 2026 for $36,880,749.10; and 33,502 shares sold April 30, 2026 for $3,094,676.90.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001181928
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MICROCHIP TECHNOLOGY INC
SEC File Number	001-42569
Address of Issuer	2355 W CHANDLER BLVD CHANDLER ARIZONA 85224-6199
Phone	480-792-7200
Name of Person for Whose Account the Securities are To Be Sold	Sanghi Steve
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 245 Summer Street Boston MA 02110	76469	7156297.84	541135458	05/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/14/2012	Option exercise	Issuer			37920	11/14/2012	N/A
Common	11/14/2024	Option exercise	Issuer			25000	11/14/2024	N/A
Common	05/15/2024	Issuer	RSU Vested			13549	05/15/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Steve Sanghi C/O MICROCHIP TECHNOLOGY INC 2355 W CHANDLER BLVD Chandler AZ 85224	Common Stock	02/12/2026	94869	7823191.83
Steve Sanghi C/O MICROCHIP TECHNOLOGY INC 2355 W CHANDLER BLVD Chandler AZ 85224	Common Stock	04/23/2026	416581	36880749.10
Steve Sanghi C/O MICROCHIP TECHNOLOGY INC 2355 W CHANDLER BLVD Chandler AZ 85224	Common Stock	04/30/2026	33502	3094676.90

144: Remarks and Signature

Remarks	Shares are being sold from THE SANGHI TRUST U/A 1/13/88
Date of Notice	05/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/06/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Audrey Skillern as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Steve Sanghi
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)